About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.


Several consortium partners currently have job opportunities related to the ConcePTION project. Would you like to contribute to our important mission? Please have a look at the current vacancies below. | READ MORE >>
On September, IMI ConcePTION has successfully launched the first of two surveys to collect information on women’s needs and preferences on information about the medicines or drugs used during pregnancy and breastfeeding. | READ MORE >>
ConcePTION: ‘Building a pan-European ecosystem for generating, monitoring, and providing robust information on medication safety in pregnancy and breastfeeding’  | READ MORE >>


Two of our consortium partners (@novonordisk and @UniOslo) currently offer job opportunities related to the ConcePTION project. Have a look at our website https://www.imi-conception.eu for additional information. @IMI_JU @EFPIA

Welcome to #SafeMotherhoodWeek 2019! It's the time of the year where we build the biggest momentum around #maternalrights & #maternalhealth. Theme for this year "Accessibility to Quality Maternal Care & Safe Medication." Take a quick glimpse now: https://bit.ly/2VFbUSk

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.


The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.